VIEMED HEALTHCARE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.06 USD | +2.32% |
|
-0.14% | -10.06% |
| 05-07 | Transcript : Viemed Healthcare, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
| 05-06 | Earnings Flash (VMD) VIEMED HEALTHCARE Reports Q1 Revenue $50.6M | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 235.3 | 303.8 | 206.8 | 287.4 | 302.1 | 267.9 | - |
| Enterprise Value (EV) 1 | 235.3 | 303.8 | 206.8 | 287.4 | 302.1 | 267.9 | 267.9 |
| P/E ratio | 29.5 x | 9.95 x | 23.7 x | 47.3 x | 31.4 x | 21.2 x | 16 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 2.93 x | 2.31 x | 1.77 x | 2.07 x | 1.65 x | 1.23 x | 1.1 x |
| EV / Revenue | 2.93 x | 2.31 x | 1.77 x | 2.07 x | 1.65 x | 1.23 x | 1.1 x |
| EV / EBITDA | 12.4 x | 7.35 x | 7.06 x | 9.58 x | 7.02 x | 5.14 x | 4.53 x |
| EV / FCF | - | - | - | - | 15.8 x | 15 x | 13.6 x |
| FCF Yield | - | - | - | - | 6.33% | 6.65% | 7.35% |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 37,953 | 39,145 | 39,608 | 38,020 | 38,489 | 38,821 | - |
| Reference price 2 | 6.200 | 7.760 | 5.220 | 7.560 | 7.850 | 6.900 | 6.900 |
| Announcement Date | 20-03-03 | 21-03-03 | 22-03-07 | 23-03-02 | 24-03-06 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 80.26 | 131.3 | 117.1 | 138.8 | 183 | 217.4 | 243.5 |
| EBITDA 1 | 19.03 | 41.33 | 29.28 | 30.02 | 43.06 | 52.1 | 59.1 |
| EBIT 1 | 9.11 | 26.78 | 11.58 | 8.252 | 14.33 | 16.5 | 18.9 |
| Operating Margin | 11.35% | 20.4% | 9.89% | 5.94% | 7.83% | 7.59% | 7.76% |
| Earnings before Tax (EBT) 1 | 8.796 | 26.36 | 12.5 | 8.99 | 14.39 | 16.2 | 18.6 |
| Net income 1 | 8.525 | 31.53 | 9.126 | 6.222 | 10.24 | 11.7 | 17.7 |
| Net margin | 10.62% | 24.01% | 7.8% | 4.48% | 5.6% | 5.38% | 7.27% |
| EPS 2 | 0.2100 | 0.7800 | 0.2200 | 0.1600 | 0.2500 | 0.3250 | 0.4300 |
| Free Cash Flow 1 | - | - | - | - | 19.12 | 17.8 | 19.7 |
| FCF margin | - | - | - | - | 10.45% | 8.19% | 8.09% |
| FCF Conversion (EBITDA) | - | - | - | - | 44.4% | 34.17% | 33.33% |
| FCF Conversion (Net income) | - | - | - | - | 186.65% | 152.14% | 111.3% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 20-03-03 | 21-03-03 | 22-03-07 | 23-03-02 | 24-03-06 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 31.96 | 32.26 | 33.31 | 35.76 | 37.51 | 39.56 | 43.31 | 49.4 | 50.74 | 50.59 | 53.8 | 55.6 | 58 |
| EBITDA 1 | 9.549 | 7.273 | 6.458 | 6.982 | 9.306 | 8.328 | 9.81 | 12.08 | 12.84 | 10.1 | 11.8 | 13 | 14.1 |
| EBIT 1 | 4.665 | 2.248 | 1.001 | 1.469 | 3.534 | 1.934 | 2.995 | 4.383 | 5.289 | 2.204 | 3.8 | 4.8 | 5.7 |
| Operating Margin | 14.6% | 6.97% | 3.01% | 4.11% | 9.42% | 4.89% | 6.92% | 8.87% | 10.42% | 4.36% | 7.06% | 8.63% | 9.83% |
| Earnings before Tax (EBT) 1 | 5.055 | 2.507 | 1.388 | 1.511 | 3.584 | 2.018 | 3.058 | 4.239 | 5.076 | 2.121 | 3.8 | 4.7 | 5.6 |
| Net income 1 | 4.087 | 1.762 | 0.967 | 1.055 | 2.438 | 1.517 | 2.33 | 2.919 | 3.477 | 1.603 | 2.7 | 3.4 | 4 |
| Net margin | 12.79% | 5.46% | 2.9% | 2.95% | 6.5% | 3.84% | 5.38% | 5.91% | 6.85% | 3.17% | 5.02% | 6.12% | 6.9% |
| EPS 2 | 0.1000 | 0.0400 | 0.0200 | 0.0300 | 0.0600 | 0.0400 | 0.0600 | 0.0700 | 0.0800 | 0.0400 | 0.0700 | 0.0800 | 0.1000 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-03-07 | 22-05-03 | 22-08-02 | 22-11-01 | 23-03-02 | 23-05-08 | 23-08-09 | 23-11-01 | 24-03-06 | 24-05-06 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | - | 19.1 | 17.8 | 19.7 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | 13 | - | - | - | - | - |
| Capex / Sales | - | 9.93% | - | - | - | - | - |
| Announcement Date | 20-03-03 | 21-03-03 | 22-03-07 | 23-03-02 | 24-03-06 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.9
USD
Average target price
12.75
USD
Spread / Average Target
+84.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.06% | 268M | |
| +17.74% | 82.59B | |
| -29.66% | 69.86B | |
| 0.00% | 26.5B | |
| +3.06% | 17.29B | |
| -12.16% | 16.61B | |
| +2.47% | 15.56B | |
| +74.82% | 13.2B | |
| +0.76% | 12.75B | |
| +73.52% | 12.6B |
- Stock Market
- Equities
- VMD Stock
- Financials Viemed Healthcare, Inc.
